Clinical Trial Update: Efficacy and Safety of CertiroBell® Tablet Plus Tacrolimus in Primary Living Donor Liver Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 trial update on CertiroBell tablet plus tacrolimus in primary living donor liver transplant recipients evaluating efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplant

Drugs mentioned

• CertiroBell
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Liver Transplant | Phase 4 | Status: UNKNOWN